A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

被引:456
作者
Marin, MC
Jost, CA
Brooks, LA
Irwin, MS
O'Nions, J
Tidy, JA
James, N
McGregor, JM
Harwood, CA
Yulug, IG
Vousden, KH
Allday, MJ
Gusterson, B
Ikawa, S
Hinds, PW
Crook, T
Kaelin, WG [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] London Sch Hyg & Trop Med, London WC1, England
[4] Inst Canc Res, Sect Cell Biol & Expt Pathol, London SW3 6JB, England
[5] Univ Sheffield, No Gen Hosp, Dept Gynecol Oncol, Sheffield S5 7AU, S Yorkshire, England
[6] Univ Birmingham, CRC, Inst Canc Studies, Birmingham, W Midlands, England
[7] Ctr Cutaneous Res, London, England
[8] NCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA
[9] St Marys Hosp, Imperial Coll Sci Technol & Med, Ludwig Inst Canc Res, London, England
[10] Tohoku Univ, Inst Dev Aging & Canc, Dept Cell Biol, Sendai, Miyagi 980, Japan
[11] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA
[12] Howard Hughes Med Inst, Coconut Grove, FL 33133 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/75586
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The p73 protein, a homologue of the tumour-suppressor protein p53, can activate p53-responsive promoters and induce apoptosis in p53-deficient cells. Here we report that some tumour-derived p53 mutants can bind to and inactivate p73. The binding of such mutants is influenced by whether TP53 (encoding p53) codon 72, by virtue of a common polymorphism in the human population, encodes Arg or Pro. The ability of mutant p53 to bind p73, neutralize p73-induced apoptosis and transform cells in cooperation with EJ-Ras was enhanced when codon 72 encoded Arg. We found that the Arg-containing allele was preferentially mutated and retained in squamous cell tumours arising in Arg/Pro germline heterozygotes. Thus, inactivation of p53 family members may contribute to the biological properties of a subset of p53 mutants, and a polymorphic residue within p53 affects mutant behaviour.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 49 条
  • [1] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [2] IS P53 POLYMORPHISM MAINTAINED BY NATURAL-SELECTION
    BECKMAN, G
    BIRGANDER, R
    SJALANDER, A
    SAHA, N
    HOLMBERG, PA
    KIVELA, A
    BECKMAN, L
    [J]. HUMAN HEREDITY, 1994, 44 (05) : 266 - 270
  • [3] P53 POLYMORPHISMS AND HAPLOTYPES IN LUNG-CANCER
    BIRGANDER, R
    SJALANDER, A
    RANNUG, A
    ALEXANDRIE, AK
    SUNDBERG, MI
    SEIDEGARD, J
    TORNLING, G
    BECKMAN, G
    BECKMAN, L
    [J]. CARCINOGENESIS, 1995, 16 (09) : 2233 - 2236
  • [4] Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy
    Blandino, G
    Levine, AJ
    Oren, M
    [J]. ONCOGENE, 1999, 18 (02) : 477 - 485
  • [5] BRACHMAN DG, 1992, CANCER RES, V52, P4832
  • [6] A ROLE FOR SUNLIGHT IN SKIN-CANCER - UV-INDUCED P53 MUTATIONS IN SQUAMOUS-CELL CARCINOMA
    BRASH, DE
    RUDOLPH, JA
    SIMON, JA
    LIN, A
    MCKENNA, GJ
    BADEN, HP
    HALPERIN, AJ
    PONTEN, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) : 10124 - 10128
  • [7] TRANSCRIPTIONAL ACTIVATION BY P53 CORRELATES WITH SUPPRESSION OF GROWTH BUT NOT TRANSFORMATION
    CROOK, T
    MARSTON, NJ
    SARA, EA
    VOUSDEN, KH
    [J]. CELL, 1994, 79 (05) : 817 - 827
  • [8] p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53
    Davison, TS
    Vagner, C
    Kaghad, M
    Ayed, A
    Caput, D
    Arrowsmith, CH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) : 18709 - 18714
  • [9] Two new p73 splice variants, γ and δ, with different transcriptional activity
    De Laurenzi, V
    Costanzo, A
    Barcaroli, D
    Terrinoni, A
    Falco, M
    Annicchiarico-Petruzzeli, M
    Levrero, M
    Melino, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) : 1763 - 1768
  • [10] Di Como CJ, 1999, MOL CELL BIOL, V19, P1438